Zevorcabtagene Autoleucel

zevorcabtagene autoleucel · CARsgen Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zevorcabtagene Autoleucel, covering 2024-10-26 to 2024-10-26. Get the full timeline:

Most recent: Clinical Trial Update: A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma

See pricing